Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Pediatr ; 129(6): 918-21, 1996 Dec.
Article de Anglais | MEDLINE | ID: mdl-8969738

RÉSUMÉ

Ovarian juvenile granulosa cell tumors are a rare cause of sexual precocity. Clinical examination, serum estradiol levels, and pelvic imaging studies have been used traditionally to detect such tumors. Immunoassays for müllerian inhibitory substance and inhibin have recently been noted to provide a more sensitive means of tumor detection in adults. We now describe two girls with this type of tumor in whom serum concentrations of inhibin and müllerian inhibitory substance were used as tumor markers.


Sujet(s)
Marqueurs biologiques tumoraux/sang , Glycoprotéines , Tumeur de la granulosa/diagnostic , Inhibiteurs de croissance/sang , Substances de croissance/sang , Inhibines/sang , Canaux de Müller , Tumeurs de l'ovaire/diagnostic , Hormones testiculaires/sang , Activines , Hormone antimullérienne , Enfant , Enfant d'âge préscolaire , Femelle , Humains
2.
N Engl J Med ; 331(15): 974-80, 1994 Oct 13.
Article de Anglais | MEDLINE | ID: mdl-7521937

RÉSUMÉ

BACKGROUND: Many patients with chronic pulmonary disease similar to that seen in cystic fibrosis have normal (or nondiagnostic) sweat chloride values. It has been difficult to make the diagnosis of cystic fibrosis in these patients because no associated mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene has been identified. METHODS: We evaluated 23 patients with pulmonary disease characteristic of cystic fibrosis but with sweat chloride concentrations in the normal range. Mutations in the CFTR gene were sought by direct sequencing of polymerase chain reaction-amplified nasal epithelial messenger RNA and by testing the functioning of affected epithelium. RESULTS: A cytidine phosphate guanosine dinucleotide C-to-T point mutation in intron 19 of the CFTR gene, termed 3849 + 10 kb C to T, was identified in 13 patients from eight unrelated families. This mutation was found in patients from three different ethnic groups with three different extended haplotypes. The mutation leads to the creation of a partially active splice site in intron 19 and to the insertion into most CFTR transcripts of a new 84-base-pair "exon," containing an in-frame stop codon, between exons 19 and 20. Normally spliced transcripts were also detected at a level approximately 8 percent of that found in normal subjects. This mutation is associated with abnormal nasal epithelial and sweat acinar epithelial function. CONCLUSIONS: We have identified a point mutation in intron 19 of CFTR and abnormal epithelial function in patients who have cystic fibrosis-like lung disease but normal sweat chloride values. The identification of this mutation indicates that this syndrome is a form of cystic fibrosis. Screening for the mutation should prove diagnostically useful in this population of patients.


Sujet(s)
Chlorures/analyse , Mucoviscidose/diagnostic , Mucoviscidose/génétique , Bronchopneumopathies obstructives/diagnostic , Sueur/composition chimique , Adolescent , Adulte , Séquence nucléotidique , Enfant , Enfant d'âge préscolaire , Canaux chlorure/métabolisme , Chromosomes humains de la paire 17 , Protéine CFTR , Femelle , Humains , Introns , Mâle , Protéines membranaires/génétique , Protéines membranaires/métabolisme , Données de séquences moléculaires , Mutation , Muqueuse nasale/métabolisme , Réaction de polymérisation en chaîne , ARN messager/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE